Over expression of NCALD gene predicts worse EFS and OS in AML patients after chemotherapy from the TCGA dataset (Fig. 2b, EFS, P = 0.011; OS, P = 0.0056; log rank test). Here, NCALD is linked to acute myeloid leukemia.